Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma.

× No keyword cloud information.

5 in total

Review 1. Brentuximab vedotin.

Authors: Niels W C J van de Donk; Eugen Dhimolea
Journal: MAbs Date: 2012-07-01 Impact factor: 5.857

Review 2. Where does brentuximab vedotin fit into the management of patients with Hodgkin lymphoma?

Authors: Sagun D Goyal; Nancy L Bartlett
Journal: Curr Hematol Malig Rep Date: 2012-09 Impact factor: 3.952

Review 3. Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients.

Authors: Neha Mehta-Shah; Nancy L Bartlett
Journal: Blood Date: 2018-03-02 Impact factor: 22.113

Review 4. Therapeutic antibodies against cancer.

Authors: Mark J Adler; Dimiter S Dimitrov
Journal: Hematol Oncol Clin North Am Date: 2012-06 Impact factor: 3.722

5. Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.

Authors: Géraldine Mitou; Julie Frentzel; Aurore Desquesnes; Sophie Le Gonidec; Talal AlSaati; Isabelle Beau; Laurence Lamant; Fabienne Meggetto; Estelle Espinos; Patrice Codogno; Pierre Brousset; Sylvie Giuriato
Journal: Oncotarget Date: 2015-10-06

5 in total